![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12185-008-0203-3/MediaObjects/12185_2008_203_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12185-008-0203-3/MediaObjects/12185_2008_203_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12185-008-0203-3/MediaObjects/12185_2008_203_Fig3_HTML.gif)
References
Swerdlow SH. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology. 1992;20:373–85. doi:10.1111/j.1365-2559.1992.tb01007.x.
Loren AW, Porter DL, Stadmauer EA, et al. Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant. 2003;31:145–55. doi:10.1038/sj.bmt.1703806.
Ghucrallah AE, Crow MK, Rice LE, et al. Multiple myeloma after cardiac transplantation: an unusual form of posttransplant lymphoproliferative disorder. Hum Pathol. 1994;25:541–5. doi:10.1016/0046-8177(94)90129-5.
Harris NL, Swerdlow SH, Frizzera G. Post-transplant lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, et al., editors. Pathology and genetics: tumors of haematopoietic and lymphoid tissues. World Health Organization classification of tumors. Lyon: IARC Press; 2001. p. 264–9.
Tcheng WY, Said J, Hall T, et al. Post-transplant multiple myeloma in a pediatric renal transplant patient. Pediatr Blood Cancer. 2006;47:218–23. doi:10.1002/pbc.20482.
Joseph G, Barker RL, Yuan B, et al. Posttransplantation plasma cell dyscrasias. Cancer. 1994;74:1959–64. doi:10.1002/1097-0142(19941001)74:7<1959::AID-CNCR2820740722>3.0.CO;2-U.
Gupta A, Shenton BK, Gok MA, et al. Plasma cell myeloma variant of post-transplant lymphoproliferative disorder in a solid organ transplant recipient: a case report. Nephrol Dial Transplant. 2005;19:3186–9. doi:10.1093/ndt/gfh433.
Hanto DW, Frizzera G, Purtillo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein–Barr virus. Cancer Res. 1981;41:4253–61.
Radl J, Valenti** RM, Haaijman JJ, et al. Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation. Clin Immunol Immunopathol. 1985;37:98–102. doi:10.1016/0090-1229(85)90140-0.
Renoult E, Bertrand F, Kessler M. Monoclonal gammmopathies in HbsAg-positive patients with renal transplants. N Engl J Med. 1988;318:1205.
Eapen M, Davies SM, Ramsay NK. Late graft rejection and second infusion of bone marrow in children with aplastic anemia. Br J Haematol. 1999;104:186–8. doi:10.1046/j.1365-2141.1999.01159.x.
Woodard P, Tong X, Richardson S, et al. Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients. J Pediatr Hematol Oncol. 2003;25:955–9. doi:10.1097/00043426-200312000-00010.
Tierens A, et al. High-resolution analysis of immunoglobulin heavy-chain gene rearrangements using denaturing gradient gel electrophoresis. Diagn Mol Pathol. 1996;5:159–65. doi:10.1097/00019606-199609000-00003.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kawakami, K., Miyanishi, S., Nakano, Y. et al. Post-transplant plasmacytoma without Epstein–Barr virus infection occurring rapidly after unrelated allogeneic bone marrow transplantation. Int J Hematol 88, 606–609 (2008). https://doi.org/10.1007/s12185-008-0203-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-008-0203-3